REPUBLIC HC (08357) plans to make an investment in Langgu Biotechnology through a capital increase and share expansion.

REPUBLIC HC (08357) announced that it has conducted in-depth and multi-dimensional discussions with Shenzhen Ronghui Renhe...

Zhitong FinanceApr 11 06:14 ET

Express News | Republic Healthcare - Co or Unit to Invest in Langgu Bio by Way of Capital Injection

ReutersApr 11 06:14 ET

REPUBLIC HC: Annual Report 2024

HKEXMar 27 06:01 ET · Announcements

REPUBLIC HC (08357) subsidiary plans to purchase Philippine property for 21.418 million pesos.

REPUBLIC HC (08357) announced that on March 26, 2025, the buyer (company among...

Zhitong FinanceMar 26 11:00 ET

REPUBLIC HC: ANNOUNCEMENT OF ANNUAL RESULTSFOR THE YEAR ENDED 31 DECEMBER 2024

HKEXMar 21 10:22 ET · Announcements

REPUBLIC HC (08357.HK) has established a Global Strategy cooperation agreement with Shenzhen Ronghui Renhe.

On December 19, Gelonghui reported that REPUBLIC HC (08357.HK) announced that on December 19, 2024, the company entered into a strategic cooperation agreement with Shenzhen Ronghui Renhe Life Technology Co., Ltd. ("Shenzhen Ronghui Renhe"). According to this agreement, both parties agreed to cooperate in three areas: (i) cell, gene, and microbiome series biotechnology products and services; (ii) Education related to Medical Care, competition guidance, and professional training for practitioners; and (iii) collaborating on the "Ark of Life" health management Institutions business to explore the Southeast Asian and international markets. According to the disclosure, Shenzhen Ronghui

Gelonghui FinanceDec 19, 2024 04:42 ET